{"transactions":[{"id":830418,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56433,"kind":"person","name":"Urbach Tanya Durkee","position":1,"cik":"0001897672","reported_name":"Urbach Tanya Durkee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-03-24T21:24:23.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":574385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027."}],"balance_after":574385,"derivative":{"exercise_price":0.28,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":574385},"source":{"system":"sec-edgar","filing":"0001104659-26-033963","document":"tm269618-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465926033963/tm269618-8_4seq1.xml","form_type":"4"}},{"id":830417,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56432,"kind":"person","name":"SIMES STEPHEN M","position":1,"cik":"0000905479","reported_name":"SIMES STEPHEN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-03-24T21:23:50.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":574385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027."}],"balance_after":574385,"derivative":{"exercise_price":0.28,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":574385},"source":{"system":"sec-edgar","filing":"0001104659-26-033962","document":"tm269618-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465926033962/tm269618-7_4seq1.xml","form_type":"4"}},{"id":830416,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56431,"kind":"person","name":"Ndhlovu Lishomwa C","position":1,"cik":"0001898357","reported_name":"Ndhlovu Lishomwa C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-03-24T21:23:14.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":574385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027."}],"balance_after":574385,"derivative":{"exercise_price":0.28,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":574385},"source":{"system":"sec-edgar","filing":"0001104659-26-033961","document":"tm269618-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465926033961/tm269618-6_4seq1.xml","form_type":"4"}},{"id":830415,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56430,"kind":"person","name":"Lalezari Jacob P","position":1,"cik":"0002001963","reported_name":"Lalezari Jacob P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-03-24T21:22:42.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":4874691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1,218,672 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030."}],"balance_after":4874691,"derivative":{"exercise_price":0.28,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":4874691},"source":{"system":"sec-edgar","filing":"0001104659-26-033960","document":"tm269618-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465926033960/tm269618-5_4seq1.xml","form_type":"4"}},{"id":830414,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-03-24T21:22:09.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":4874691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1,218,672 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030."}],"balance_after":4874691,"derivative":{"exercise_price":0.28,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":4874691},"source":{"system":"sec-edgar","filing":"0001104659-26-033958","document":"tm269618-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465926033958/tm269618-4_4seq1.xml","form_type":"4"}},{"id":830413,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56429,"kind":"person","name":"Dunlap Ryan","position":1,"cik":"0001554742","reported_name":"Dunlap Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-03-24T21:21:33.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":574385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027."}],"balance_after":574385,"derivative":{"exercise_price":0.28,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":574385},"source":{"system":"sec-edgar","filing":"0001104659-26-033957","document":"tm269618-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465926033957/tm269618-3_4seq1.xml","form_type":"4"}},{"id":830412,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56428,"kind":"person","name":"Brunke Karen J","position":1,"cik":"0001922660","reported_name":"Brunke Karen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-03-24T21:20:57.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":574385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027."}],"balance_after":574385,"derivative":{"exercise_price":0.28,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":574385},"source":{"system":"sec-edgar","filing":"0001104659-26-033955","document":"tm269618-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465926033955/tm269618-2_4seq1.xml","form_type":"4"}},{"id":830411,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56427,"kind":"person","name":"Blok Tyler","position":1,"cik":"0001990234","reported_name":"Blok Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-03-24T21:20:20.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":3249794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"812,448 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030."}],"balance_after":3249794,"derivative":{"exercise_price":0.28,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":3249794},"source":{"system":"sec-edgar","filing":"0001104659-26-033954","document":"tm269618-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465926033954/tm269618-1_4seq1.xml","form_type":"4"}},{"id":1138433,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2025-05-23T00:31:53.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee effective May 15, 2025, pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"250,000 shares will vest on May 15, 2026, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Plan ) from May 2026 through April 2029."}],"balance_after":1000000,"derivative":{"exercise_price":0.41,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001104659-25-052122","document":"tm2515909-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465925052122/tm2515909-2_4seq1.xml","form_type":"4"}},{"id":1379774,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56433,"kind":"person","name":"Urbach Tanya Durkee","position":1,"cik":"0001897672","reported_name":"Urbach Tanya Durkee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-10-31T01:48:58.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025."}],"balance_after":800000,"derivative":{"exercise_price":0.13,"expiration_date":"2034-10-28","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-112761","document":"tm2427081-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924112761/tm2427081-7_4seq1.xml","form_type":"4"}},{"id":1379773,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56432,"kind":"person","name":"SIMES STEPHEN M","position":1,"cik":"0000905479","reported_name":"SIMES STEPHEN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-10-31T01:48:24.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025."}],"balance_after":800000,"derivative":{"exercise_price":0.13,"expiration_date":"2034-10-28","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-112760","document":"tm2427081-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924112760/tm2427081-6_4seq1.xml","form_type":"4"}},{"id":1379772,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56431,"kind":"person","name":"Ndhlovu Lishomwa C","position":1,"cik":"0001898357","reported_name":"Ndhlovu Lishomwa C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-10-31T01:47:46.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025."}],"balance_after":800000,"derivative":{"exercise_price":0.13,"expiration_date":"2034-10-28","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-112758","document":"tm2427081-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924112758/tm2427081-5_4seq1.xml","form_type":"4"}},{"id":1379770,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56430,"kind":"person","name":"Lalezari Jacob P","position":1,"cik":"0002001963","reported_name":"Lalezari Jacob P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-10-31T01:47:09.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"250,000 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2028."}],"balance_after":3000000,"derivative":{"exercise_price":0.13,"expiration_date":"2034-10-28","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001104659-24-112757","document":"tm2427081-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924112757/tm2427081-4_4seq1.xml","form_type":"4"}},{"id":1379771,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56429,"kind":"person","name":"Dunlap Ryan","position":1,"cik":"0001554742","reported_name":"Dunlap Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-10-31T01:46:22.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025."}],"balance_after":800000,"derivative":{"exercise_price":0.13,"expiration_date":"2034-10-28","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-112756","document":"tm2427081-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924112756/tm2427081-3_4seq1.xml","form_type":"4"}},{"id":1379769,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56428,"kind":"person","name":"Brunke Karen J","position":1,"cik":"0001922660","reported_name":"Brunke Karen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-10-31T01:45:43.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025."}],"balance_after":800000,"derivative":{"exercise_price":0.13,"expiration_date":"2034-10-28","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-112755","document":"tm2427081-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924112755/tm2427081-2_4seq1.xml","form_type":"4"}},{"id":1379768,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56427,"kind":"person","name":"Blok Tyler","position":1,"cik":"0001990234","reported_name":"Blok Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-10-31T01:45:06.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"104,164 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2028."}],"balance_after":1250000,"derivative":{"exercise_price":0.13,"expiration_date":"2034-10-28","underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001104659-24-112753","document":"tm2427081-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924112753/tm2427081-1_4seq1.xml","form_type":"4"}},{"id":1588286,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56430,"kind":"person","name":"Lalezari Jacob P","position":1,"cik":"0002001963","reported_name":"Lalezari Jacob P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-03-09T02:30:20.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable in 48 monthly installments beginning on April 7, 2024 and ending on March 7, 2028, subject to Continuous Service (as the term is defined in the Issuer's  2012 Equity Incentive Plan, as amended) through the applicable vesting date."}],"balance_after":3000000,"derivative":{"exercise_price":0.21,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001104659-24-032609","document":"tm248303-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924032609/tm248303-1_4seq1.xml","form_type":"4"}},{"id":1686720,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":630222,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"301,975 shares were fully vested and exercisable on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through January 2026."}],"balance_after":630222,"derivative":{"exercise_price":0.21,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":630222},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686719,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"666,000 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on August 6, 2024."}],"balance_after":1000000,"derivative":{"exercise_price":0.21,"expiration_date":"2031-08-06","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686718,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"33,300 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on February 17, 2024."}],"balance_after":50000,"derivative":{"exercise_price":0.21,"expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686717,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."}],"balance_after":100000,"derivative":{"exercise_price":0.21,"exercise_date":"2024-01-03","expiration_date":"2030-07-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686716,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."}],"balance_after":50000,"derivative":{"exercise_price":0.21,"exercise_date":"2024-01-03","expiration_date":"2030-02-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686715,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."}],"balance_after":50000,"derivative":{"exercise_price":0.21,"exercise_date":"2024-01-03","expiration_date":"2030-01-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686714,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":630222,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the award vested on January 24, 2023, with the balance scheduled to vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.58,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":630222},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686713,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vesting was scheduled to occur in three equal annual installments beginning on August 6, 2022."}],"balance_after":0,"derivative":{"exercise_price":1.32,"expiration_date":"2031-08-06","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686712,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vesting was scheduled to occur in three equal annual installments beginning on February 17, 2022."}],"balance_after":0,"derivative":{"exercise_price":5.54,"expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686711,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was fully vested and exercisable prior to January 3, 2024."}],"balance_after":0,"derivative":{"exercise_price":5.57,"expiration_date":"2030-07-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686710,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was fully vested and exercisable prior to January 3, 2024."}],"balance_after":0,"derivative":{"exercise_price":1.1,"expiration_date":"2030-02-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686709,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:57.000Z","date":"2024-01-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was fully vested and exercisable prior to January 3, 2024."}],"balance_after":0,"derivative":{"exercise_price":1.03,"expiration_date":"2030-01-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-001956","document":"tm242134-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001956/tm242134-7_4seq1.xml","form_type":"4"}},{"id":1686707,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56433,"kind":"person","name":"Urbach Tanya Durkee","position":1,"cik":"0001897672","reported_name":"Urbach Tanya Durkee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:04:20.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024."}],"balance_after":800000,"derivative":{"exercise_price":0.21,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-001955","document":"tm242134-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001955/tm242134-6_4seq1.xml","form_type":"4"}},{"id":1686708,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56432,"kind":"person","name":"SIMES STEPHEN M","position":1,"cik":"0000905479","reported_name":"SIMES STEPHEN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:03:49.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024."}],"balance_after":800000,"derivative":{"exercise_price":0.21,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-001954","document":"tm242134-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001954/tm242134-5_4seq1.xml","form_type":"4"}},{"id":1686706,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56431,"kind":"person","name":"Ndhlovu Lishomwa C","position":1,"cik":"0001898357","reported_name":"Ndhlovu Lishomwa C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:02:59.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024."}],"balance_after":800000,"derivative":{"exercise_price":0.21,"expiration_date":"2024-01-03","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-001953","document":"tm242134-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001953/tm242134-4_4seq1.xml","form_type":"4"}},{"id":1686704,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56429,"kind":"person","name":"Dunlap Ryan","position":1,"cik":"0001554742","reported_name":"Dunlap Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:02:30.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024."}],"balance_after":800000,"derivative":{"exercise_price":0.21,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-001952","document":"tm242134-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001952/tm242134-3_4seq1.xml","form_type":"4"}},{"id":1686705,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56428,"kind":"person","name":"Brunke Karen J","position":1,"cik":"0001922660","reported_name":"Brunke Karen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:01:55.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024."}],"balance_after":800000,"derivative":{"exercise_price":0.21,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-24-001951","document":"tm242134-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001951/tm242134-2_4seq1.xml","form_type":"4"}},{"id":1686703,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56427,"kind":"person","name":"Blok Tyler","position":1,"cik":"0001990234","reported_name":"Blok Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Legal Affairs"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:01:14.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"145,831 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through May 2027."}],"balance_after":1000000,"derivative":{"exercise_price":0.21,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001104659-24-001950","document":"tm242134-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001950/tm242134-1_4seq1.xml","form_type":"4"}},{"id":1686702,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56427,"kind":"person","name":"Blok Tyler","position":1,"cik":"0001990234","reported_name":"Blok Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Legal Affairs"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:01:14.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"35,415 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through July 2026."}],"balance_after":100000,"derivative":{"exercise_price":0.21,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-24-001950","document":"tm242134-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001950/tm242134-1_4seq1.xml","form_type":"4"}},{"id":1686701,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56427,"kind":"person","name":"Blok Tyler","position":1,"cik":"0001990234","reported_name":"Blok Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Legal Affairs"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:01:14.000Z","date":"2024-01-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the grant vested on July 25, 2023, with the balance vesting in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) beginning at the end of August 2023 through July 2026."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-24-001950","document":"tm242134-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001950/tm242134-1_4seq1.xml","form_type":"4"}},{"id":2018855,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":116966,"kind":"person","name":"Arman Arvin Cyrus","position":1,"cik":"0001939191","reported_name":"Arman Arvin Cyrus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Warrants (right to buy)","published_at":"2023-02-15T01:09:49.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":434782,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are included within Units purchased by the reporting person in a private placement directly with the Company. The terms are identical to a concurrent offering being conducted through a placement agent (the \"Offering\"). Each \"Unit\" consists of one share of common stock and one warrant to purchase one share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrants will become exercisable in full on the final closing date of the Offering. The warrants will expire five years after the exercise date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrants will become exercisable in full on the final closing date of the Offering. The warrants will expire five years after the exercise date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The reported securities are included within Units purchased by the reporting person in a private placement directly with the Company. The terms are identical to a concurrent offering being conducted through a placement agent (the \"Offering\"). Each \"Unit\" consists of one share of common stock and one warrant to purchase one share of common stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price."}],"balance_after":434782,"derivative":{"exercise_price":0.5,"underlying":"Common Stock","underlying_shares":434782},"source":{"system":"sec-edgar","filing":"0001104659-23-022094","document":"tm236870-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465923022094/tm236870-1_4seq1.xml","form_type":"4"}},{"id":2018854,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":116966,"kind":"person","name":"Arman Arvin Cyrus","position":1,"cik":"0001939191","reported_name":"Arman Arvin Cyrus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-02-15T01:09:49.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":434782,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are included within Units purchased by the reporting person in a private placement directly with the Company. The terms are identical to a concurrent offering being conducted through a placement agent (the \"Offering\"). Each \"Unit\" consists of one share of common stock and one warrant to purchase one share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price."}],"balance_after":1081334,"source":{"system":"sec-edgar","filing":"0001104659-23-022094","document":"tm236870-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465923022094/tm236870-1_4seq1.xml","form_type":"4"}},{"id":2102008,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-12-01T01:34:42.000Z","date":"2022-11-28","kind":"grant","acquired":true,"shares":4585536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"477,660 shares vested on November 28, 2022; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from November 2022 through May 2026."}],"balance_after":4585536,"derivative":{"exercise_price":0.35,"expiration_date":"2032-11-28","underlying":"Common Stock","underlying_shares":4585536},"source":{"system":"sec-edgar","filing":"0001104659-22-123366","document":"tm2231600-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922123366/tm2231600-4_4seq1.xml","form_type":"4"}},{"id":2102007,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-12-01T01:34:42.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":12008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":183207,"source":{"system":"sec-edgar","filing":"0001104659-22-123366","document":"tm2231600-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922123366/tm2231600-4_4seq1.xml","form_type":"4"}},{"id":2102006,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-12-01T01:33:01.000Z","date":"2022-11-28","kind":"grant","acquired":true,"shares":2315439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"241,190 shares vested on November 28, 2022; the balance will vest on a monthly basis as follows (i) 48,238 shares at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended), from November 2022 through February 2025, and (ii) 48,239 shares at the conclusion of each month of Continuous Service, from March 2025 through May 2026."}],"balance_after":2315439,"derivative":{"exercise_price":0.35,"expiration_date":"2032-11-28","underlying":"Common Stock","underlying_shares":2315439},"source":{"system":"sec-edgar","filing":"0001104659-22-123365","document":"tm2231600-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922123365/tm2231600-3_4seq1.xml","form_type":"4"}},{"id":2102005,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-12-01T01:33:01.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":16927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2184037,"source":{"system":"sec-edgar","filing":"0001104659-22-123365","document":"tm2231600-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922123365/tm2231600-3_4seq1.xml","form_type":"4"}},{"id":2113823,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-11-17T23:53:17.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":10807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":171199,"source":{"system":"sec-edgar","filing":"0001104659-22-119981","document":"tm2230762-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922119981/tm2230762-3_4seq1.xml","form_type":"4"}},{"id":2113822,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-11-17T23:51:35.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":15234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2167110,"source":{"system":"sec-edgar","filing":"0001104659-22-119979","document":"tm2230762-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922119979/tm2230762-2_4seq1.xml","form_type":"4"}},{"id":2113821,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-11-17T23:49:53.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":13671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":500090,"source":{"system":"sec-edgar","filing":"0001104659-22-119978","document":"tm2230762-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922119978/tm2230762-1_4seq1.xml","form_type":"4"}},{"id":2128093,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-11-03T00:57:14.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":17922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2151876,"source":{"system":"sec-edgar","filing":"0001104659-22-114101","document":"tm2228860-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922114101/tm2228860-4_4seq1.xml","form_type":"4"}},{"id":2128090,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-11-03T00:55:09.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":12714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":160392,"source":{"system":"sec-edgar","filing":"0001104659-22-114100","document":"tm2228860-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922114100/tm2228860-3_4seq1.xml","form_type":"4"}},{"id":2128088,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-11-03T00:52:48.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":16084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":486419,"source":{"system":"sec-edgar","filing":"0001104659-22-114098","document":"tm2228860d2_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922114098/tm2228860d2_4seq.xml","form_type":"4"}},{"id":2129232,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56432,"kind":"person","name":"SIMES STEPHEN M","position":1,"cik":"0000905479","reported_name":"SIMES STEPHEN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-11-01T21:04:05.000Z","date":"2022-10-24","kind":"grant","acquired":true,"shares":178012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in eight equal monthly installments beginning on November 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date."}],"balance_after":178012,"derivative":{"exercise_price":0.43,"expiration_date":"2032-10-24","underlying":"Common Stock","underlying_shares":178012},"source":{"system":"sec-edgar","filing":"0001104659-22-113563","document":"tm2228860-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922113563/tm2228860-1_4seq1.xml","form_type":"4"}},{"id":2136057,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-10-18T20:04:17.000Z","date":"2022-10-15","kind":"grant","acquired":true,"shares":12428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":470335,"source":{"system":"sec-edgar","filing":"0001104659-22-109693","document":"tm2228392-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922109693/tm2228392-3_4seq1.xml","form_type":"4"}},{"id":2136056,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-10-18T20:03:15.000Z","date":"2022-10-15","kind":"grant","acquired":true,"shares":9824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":147678,"source":{"system":"sec-edgar","filing":"0001104659-22-109690","document":"tm2228392-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922109690/tm2228392-2_4seq1.xml","form_type":"4"}},{"id":2136055,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-10-18T20:02:38.000Z","date":"2022-10-15","kind":"grant","acquired":true,"shares":13849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2133954,"source":{"system":"sec-edgar","filing":"0001104659-22-109687","document":"tm2228392-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922109687/tm2228392-1_4seq1.xml","form_type":"4"}},{"id":2146562,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-10-04T23:19:21.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":18793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in\nreporting person's cash salary."}],"balance_after":2120105,"source":{"system":"sec-edgar","filing":"0001104659-22-105980","document":"tm2227293-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922105980/tm2227293-1_4seq1.xml","form_type":"4"}},{"id":2146561,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-10-04T23:17:24.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":13020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in\nreporting person's cash salary."}],"balance_after":457907,"source":{"system":"sec-edgar","filing":"0001104659-22-105983","document":"tm2227293-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922105983/tm2227293-3_4seq1.xml","form_type":"4"}},{"id":2146559,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-10-04T23:14:50.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":10292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":137854,"source":{"system":"sec-edgar","filing":"0001104659-22-105981","document":"tm2227293-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922105981/tm2227293-2_4seq1.xml","form_type":"4"}},{"id":2153169,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-09-23T00:21:39.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":630222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the award will vest on January 24, 2023; thereafter, the balance will vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date."}],"balance_after":630222,"derivative":{"exercise_price":0.58,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":630222},"source":{"system":"sec-edgar","filing":"0001104659-22-102417","document":"tm2226067-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922102417/tm2226067-5_4seq1.xml","form_type":"4"}},{"id":2153168,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":116966,"kind":"person","name":"Arman Arvin Cyrus","position":1,"cik":"0001939191","reported_name":"Arman Arvin Cyrus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-09-23T00:20:16.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":1575557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the award will vest on July 9, 2023; thereafter, the balance will vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Plan) through the applicable vesting date."}],"balance_after":1575557,"derivative":{"exercise_price":0.58,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":1575557},"source":{"system":"sec-edgar","filing":"0001104659-22-102416","document":"tm2226067-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922102416/tm2226067-4_4seq1.xml","form_type":"4"}},{"id":2153167,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":116966,"kind":"person","name":"Arman Arvin Cyrus","position":1,"cik":"0001939191","reported_name":"Arman Arvin Cyrus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-09-23T00:20:16.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":646552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the \"Plan\"). The RSUs will vest in four (4) equal annual installments beginning July 9, 2023, subject to Continuous Service (as the term is defined in the Plan) through the applicable vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the \"Plan\"). The RSUs will vest in four (4) equal annual installments beginning July 9, 2023, subject to Continuous Service (as the term is defined in the Plan) through the applicable vesting date."}],"balance_after":646552,"source":{"system":"sec-edgar","filing":"0001104659-22-102416","document":"tm2226067-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922102416/tm2226067-4_4seq1.xml","form_type":"4"}},{"id":2156770,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-09-19T23:33:38.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":9457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2101312,"source":{"system":"sec-edgar","filing":"0001104659-22-101258","document":"tm2226067-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922101258/tm2226067-3_4seq1.xml","form_type":"4"}},{"id":2156769,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-09-19T23:31:32.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":8965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":444887,"source":{"system":"sec-edgar","filing":"0001104659-22-101254","document":"tm2226067-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922101254/tm2226067-1_4seq1.xml","form_type":"4"}},{"id":2156768,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-09-19T23:30:47.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":7086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":127562,"source":{"system":"sec-edgar","filing":"0001104659-22-101256","document":"tm2226067-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922101256/tm2226067-2_4seq1.xml","form_type":"4"}},{"id":2163788,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56428,"kind":"person","name":"Brunke Karen J","position":1,"cik":"0001922660","reported_name":"Brunke Karen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-09-09T01:50:26.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":247111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As of August 31, 2022, 61,777 shares have vested; the balance will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date."}],"balance_after":247111,"derivative":{"exercise_price":0.5,"expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":247111},"source":{"system":"sec-edgar","filing":"0001104659-22-098631","document":"tm2225305-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922098631/tm2225305-3_4seq1.xml","form_type":"4"}},{"id":2163787,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56428,"kind":"person","name":"Brunke Karen J","position":1,"cik":"0001922660","reported_name":"Brunke Karen J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-09-09T01:50:26.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37500,"derivative":{"exercise_price":0.5,"exercise_date":"2022-09-06","expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001104659-22-098631","document":"tm2225305-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922098631/tm2225305-3_4seq1.xml","form_type":"4"}},{"id":2163786,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56431,"kind":"person","name":"Ndhlovu Lishomwa C","position":1,"cik":"0001898357","reported_name":"Ndhlovu Lishomwa C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-09-09T01:50:09.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":247111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As of August 31, 2022, 61,777 shares have vested; the balance will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date."}],"balance_after":247111,"derivative":{"exercise_price":0.5,"expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":247111},"source":{"system":"sec-edgar","filing":"0001104659-22-098630","document":"tm2225305-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922098630/tm2225305-5_4seq1.xml","form_type":"4"}},{"id":2163785,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56431,"kind":"person","name":"Ndhlovu Lishomwa C","position":1,"cik":"0001898357","reported_name":"Ndhlovu Lishomwa C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-09-09T01:50:09.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":0.5,"exercise_date":"2022-09-06","expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-22-098630","document":"tm2225305-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922098630/tm2225305-5_4seq1.xml","form_type":"4"}},{"id":2163784,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56431,"kind":"person","name":"Ndhlovu Lishomwa C","position":1,"cik":"0001898357","reported_name":"Ndhlovu Lishomwa C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-09-09T01:50:09.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":112500,"derivative":{"exercise_price":0.5,"exercise_date":"2022-09-06","expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001104659-22-098630","document":"tm2225305-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922098630/tm2225305-5_4seq1.xml","form_type":"4"}},{"id":2163783,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56429,"kind":"person","name":"Dunlap Ryan","position":1,"cik":"0001554742","reported_name":"Dunlap Ryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-09-09T01:49:01.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":185333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date."}],"balance_after":185333,"derivative":{"exercise_price":0.5,"expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":185333},"source":{"system":"sec-edgar","filing":"0001104659-22-098629","document":"tm2225305-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922098629/tm2225305-2_4seq1.xml","form_type":"4"}},{"id":2163780,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56433,"kind":"person","name":"Urbach Tanya Durkee","position":1,"cik":"0001897672","reported_name":"Urbach Tanya Durkee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-09-09T01:48:45.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":247111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As of August 31, 2022, 61,777 shares have vested; the balance will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date."}],"balance_after":241111,"derivative":{"exercise_price":0.5,"expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":247111},"source":{"system":"sec-edgar","filing":"0001104659-22-098628","document":"tm2225305-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922098628/tm2225305-4_4seq1.xml","form_type":"4"}},{"id":2163779,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56433,"kind":"person","name":"Urbach Tanya Durkee","position":1,"cik":"0001897672","reported_name":"Urbach Tanya Durkee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2022-09-09T01:48:45.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":112500,"derivative":{"exercise_price":0.5,"exercise_date":"2022-09-06","expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001104659-22-098628","document":"tm2225305-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922098628/tm2225305-4_4seq1.xml","form_type":"4"}},{"id":2168615,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-09-02T23:59:10.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":8313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":120476,"source":{"system":"sec-edgar","filing":"0001104659-22-097604","document":"tm2221304-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922097604/tm2221304-8_4seq1.xml","form_type":"4"}},{"id":2168614,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-09-02T23:57:44.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":11094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2091855,"source":{"system":"sec-edgar","filing":"0001104659-22-097603","document":"tm2221304-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922097603/tm2221304-7_4seq1.xml","form_type":"4"}},{"id":2168613,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-09-02T23:56:08.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":10516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":435922,"source":{"system":"sec-edgar","filing":"0001104659-22-097602","document":"tm2221304-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922097602/tm2221304-9_4seq1.xml","form_type":"4"}},{"id":2183247,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-08-17T20:04:21.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":6588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":425406,"source":{"system":"sec-edgar","filing":"0001104659-22-092175","document":"tm2221304-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922092175/tm2221304-6_4seq1.xml","form_type":"4"}},{"id":2183245,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-08-17T20:02:32.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":6950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2080761,"source":{"system":"sec-edgar","filing":"0001104659-22-092174","document":"tm2221304-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922092174/tm2221304-5_4seq1.xml","form_type":"4"}},{"id":2183244,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-08-17T20:02:02.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":112163,"source":{"system":"sec-edgar","filing":"0001104659-22-092173","document":"tm2221304-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922092173/tm2221304-4_4seq1.xml","form_type":"4"}},{"id":2195006,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-08-04T20:11:36.000Z","date":"2022-07-31","kind":"grant","acquired":true,"shares":7102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":418818,"source":{"system":"sec-edgar","filing":"0001104659-22-086132","document":"tm2222420-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922086132/tm2222420-3_4seq1.xml","form_type":"4"}},{"id":2195005,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Interim President"}}],"security":"Common Stock","published_at":"2022-08-04T20:09:40.000Z","date":"2022-07-31","kind":"grant","acquired":true,"shares":5614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in\nreporting person's cash salary."}],"balance_after":106955,"source":{"system":"sec-edgar","filing":"0001104659-22-086125","document":"tm2222420-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922086125/tm2222420-2_4seq1.xml","form_type":"4"}},{"id":2195004,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-08-04T20:06:07.000Z","date":"2022-07-31","kind":"grant","acquired":true,"shares":7492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2073811,"source":{"system":"sec-edgar","filing":"0001104659-22-086117","document":"tm2222420-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922086117/tm2222420-1_4seq1.xml","form_type":"4"}},{"id":2206021,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-07-19T20:03:03.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":12428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":411716,"source":{"system":"sec-edgar","filing":"0001104659-22-080838","document":"tm2221304-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922080838/tm2221304-3_4seq1.xml","form_type":"4"}},{"id":2206020,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Interim President"}}],"security":"Common Stock","published_at":"2022-07-19T20:02:35.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":9824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":101341,"source":{"system":"sec-edgar","filing":"0001104659-22-080837","document":"tm2221304-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922080837/tm2221304-2_4seq1.xml","form_type":"4"}},{"id":2206019,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-07-19T20:02:27.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":13112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2066319,"source":{"system":"sec-edgar","filing":"0001104659-22-080836","document":"tm2221304-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922080836/tm2221304-1_4seq1.xml","form_type":"4"}},{"id":2216280,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-07-05T21:17:29.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":13020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":399288,"source":{"system":"sec-edgar","filing":"0001104659-22-077436","document":"tm2220248-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922077436/tm2220248-3_4seq1.xml","form_type":"4"}},{"id":2216279,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Interim President"}}],"security":"Common Stock","published_at":"2022-07-05T21:16:20.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":10292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":91517,"source":{"system":"sec-edgar","filing":"0001104659-22-077435","document":"tm2220248-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922077435/tm2220248-2_4seq1.xml","form_type":"4"}},{"id":2216277,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-07-05T21:14:55.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":13736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2053207,"source":{"system":"sec-edgar","filing":"0001104659-22-077432","document":"tm2220248-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922077432/tm2220248-1_4seq1.xml","form_type":"4"}},{"id":2226325,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-06-21T20:50:12.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":13671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":386268,"source":{"system":"sec-edgar","filing":"0001104659-22-073013","document":"tm2218921-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922073013/tm2218921-3_4seq1.xml","form_type":"4"}},{"id":2226323,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":95446,"kind":"person","name":"Migliarese Antonio","position":1,"cik":"0001864040","reported_name":"Migliarese Antonio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Interim President"}}],"security":"Common Stock","published_at":"2022-06-21T20:48:20.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":10807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":81225,"source":{"system":"sec-edgar","filing":"0001104659-22-073010","document":"tm2218921-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922073010/tm2218921-2_4seq1.xml","form_type":"4"}},{"id":2226322,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-06-21T20:45:07.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":14423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2039471,"source":{"system":"sec-edgar","filing":"0001104659-22-073001","document":"tm2218921-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922073001/tm2218921-1_4seq1.xml","form_type":"4"}},{"id":2239773,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-06-08T20:08:03.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":18029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2025048,"source":{"system":"sec-edgar","filing":"0001104659-22-069307","document":"tm2217755-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069307/tm2217755-4_4seq1.xml","form_type":"4"}},{"id":2239772,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-06-08T20:08:03.000Z","date":"2022-05-15","kind":"grant","acquired":true,"shares":16968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":2007019,"source":{"system":"sec-edgar","filing":"0001104659-22-069307","document":"tm2217755-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069307/tm2217755-4_4seq1.xml","form_type":"4"}},{"id":2239771,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-06-08T20:08:03.000Z","date":"2022-04-30","kind":"grant","acquired":true,"shares":18029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":1990051,"source":{"system":"sec-edgar","filing":"0001104659-22-069307","document":"tm2217755-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069307/tm2217755-4_4seq1.xml","form_type":"4"}},{"id":2239770,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-06-08T20:08:03.000Z","date":"2022-04-15","kind":"grant","acquired":true,"shares":21367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":1972022,"source":{"system":"sec-edgar","filing":"0001104659-22-069307","document":"tm2217755-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069307/tm2217755-4_4seq1.xml","form_type":"4"}},{"id":2239769,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":121995,"kind":"person","name":"Kelly Scott A.","position":1,"cik":"0001703394","reported_name":"Kelly Scott A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2022-06-08T20:08:03.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":15592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":1950655,"source":{"system":"sec-edgar","filing":"0001104659-22-069307","document":"tm2217755-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069307/tm2217755-4_4seq1.xml","form_type":"4"}},{"id":2239768,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-06-08T20:07:12.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":17089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":372597,"source":{"system":"sec-edgar","filing":"0001104659-22-069303","document":"tm2217755-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069303/tm2217755-3_4seq1.xml","form_type":"4"}},{"id":2239767,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-06-08T20:07:12.000Z","date":"2022-05-15","kind":"grant","acquired":true,"shares":16084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":355508,"source":{"system":"sec-edgar","filing":"0001104659-22-069303","document":"tm2217755-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069303/tm2217755-3_4seq1.xml","form_type":"4"}},{"id":2239766,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-06-08T20:07:12.000Z","date":"2022-04-30","kind":"grant","acquired":true,"shares":17089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":339424,"source":{"system":"sec-edgar","filing":"0001104659-22-069303","document":"tm2217755-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069303/tm2217755-3_4seq1.xml","form_type":"4"}},{"id":2239765,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-06-08T20:07:12.000Z","date":"2022-04-15","kind":"grant","acquired":true,"shares":20254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":322335,"source":{"system":"sec-edgar","filing":"0001104659-22-069303","document":"tm2217755-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069303/tm2217755-3_4seq1.xml","form_type":"4"}},{"id":2239764,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":122325,"kind":"person","name":"Ray Nitya G.","position":1,"cik":"0001709522","reported_name":"Ray Nitya G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-06-08T20:07:12.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":14780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary."}],"balance_after":302081,"source":{"system":"sec-edgar","filing":"0001104659-22-069303","document":"tm2217755-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069303/tm2217755-3_4seq1.xml","form_type":"4"}},{"id":2239763,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":126434,"kind":"person","name":"Recknor Chris P","position":1,"cik":"0001850917","reported_name":"Recknor Chris P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-06-08T20:06:27.000Z","date":"2022-04-15","kind":"grant","acquired":true,"shares":17746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in\nreporting person's cash salary."}],"balance_after":716746,"source":{"system":"sec-edgar","filing":"0001104659-22-069300","document":"tm2217755-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069300/tm2217755-2_4seq1.xml","form_type":"4"}},{"id":2239762,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":126434,"kind":"person","name":"Recknor Chris P","position":1,"cik":"0001850917","reported_name":"Recknor Chris P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-06-08T20:06:27.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":12950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in\nreporting person's cash salary."}],"balance_after":699000,"source":{"system":"sec-edgar","filing":"0001104659-22-069300","document":"tm2217755-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465922069300/tm2217755-2_4seq1.xml","form_type":"4"}}],"next_cursor":"2022-06-08T20:06:27.000000Z,2239762"}